Gastroenterology | |
|---|---|
| Study Name | Principal Investigator |
| I6T-MC-AMAX – A Phase 3, Multicenter, Open-Label, Long-Term Extension Study to Evaluate the Long-Term Efficacy and Safety of Mirikizumab in Patients with Crohn’s Disease. Read more. |
Mitchell Spinnell, MD |
